[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
April 28, 1999

Serogroup B Meningococcal DiseaseNew Outbreaks, New Strategies

Author Affiliations

Author Affiliation: Expanded Programme on Immunization, Vaccines and Other Biologicals, Health Technology and Pharmaceuticals, World Health Organization, Geneva, Switzerland.

JAMA. 1999;281(16):1541-1543. doi:10.1001/jama.281.16.1541

Meningococcal disease is among the most feared infections of children and young adults because of the rapidity of onset, high mortality rate, devastating sequelae, and tendency to spread and cause outbreaks. Two articles in this issue of THE JOURNAL1,2 highlight the challenge of serogroup B meningococci—the most common cause of meningococcal disease in many countries.

First Page Preview View Large
First page PDF preview
First page PDF preview
×